Cagrilintide is a synthetic peptide that mimics the effects of the hormone amylin, which plays a key role in regulating appetite and blood sugar. It works by slowing gastric emptying and promoting a sense of fullness, which helps reduce overall food intake. Additionally, it stabilizes blood glucose levels and suppresses hunger, making it an effective treatment for weight management and metabolic conditions such as type 2 diabetes.
Clinical studies have shown that Cagrilintide, particularly in combination with other therapies like Semaglutide, enhances weight loss more effectively than when used alone. In trials, the peptide contributed to significant weight reductions—up to 17% when combined with Semaglutide. This combination offers a comprehensive approach by targeting both appetite control and glucose metabolism.
